MoneyWorks4Me

Valiant Laboratories - Quaterly Results

07 Feb 2025 Evaluate
Net sales declined -13.05%  to  Rs. 352.28 million from Rs. 405.15 millions.The Total Profit for the quarter ended December 2024 of Rs. 16.00 millions grew from Rs.-35.03 millions Operating profit Margin for the quarter ended December 2024 improved to 12.90% as compared to -45.32% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 352.28 405.15 -13.05 755.91 1514.70 -50.10 1820.52 3339.10 -45.48
Other Income 6.66 17.75 -62.48 47.74 71.78 -33.49 96.82 48.63 99.10
PBIDT 12.90 -45.32 -128.46 -37.31 32.99 -213.09 12.73 399.54 -96.81
Interest 0.62 0.19 226.32 1.21 0.57 112.28 0.78 2.54 -69.29
PBDT 12.28 -45.51 -126.98 -38.52 32.42 -218.82 11.95 397.00 -96.99
Depreciation 5.09 4.94 3.04 15.19 14.46 5.05 19.48 15.63 24.63
PBT 7.19 -50.45 -114.25 -53.71 17.96 -399.05 -7.53 381.37 -101.97
TAX -8.81 -15.42 -42.87 0.17 2.38 -92.86 -10.93 91.38 -111.96
Deferred Tax -8.81 -2.06 327.67 0.17 -3.58 -104.75 -1.11 3.38 -132.84
PAT 16.00 -35.03 -145.68 -53.88 15.58 -445.83 3.40 289.99 -98.83
Equity 434.50 434.50 0.00 434.50 434.50 0.00 434.50 325.60 33.45
PBIDTM(%) 3.66 -11.19 -132.74 -4.94 2.18 -326.62 0.70 11.97 -94.16
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..